- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03569319
Tailored Mediterranean Lifestyle Education in Participants With Subjective Cognitive Impairment
The Development and Pilot Testing of Tailored Mediterranean Lifestyle Education to Encourage Behaviour Change in Participants With Subjective Cognitive Impairment
It is estimated that 30% of Alzheimer's disease cases globally are associated with changeable risk factors, such as diet and physical activity. In particular, a Mediterranean diet (MD) has been associated with reduced risk of cognitive decline and improved brain function.
The investigators developed educational resources on the Mediterranean diet and lifestyle (THINK-MED) in accordance with the Medical Research Council guidance for developing and evaluating complex interventions, based on a systematic literature review and informed by qualitative work with patients with mild memory problems.The feedback gathered informed refinements and tailoring of the resource and overall MD intervention.
This study aims to evaluate feasibility of the "THINK-MED" Mediterranean lifestyle educational intervention to encourage dietary behaviour change among community-dwelling people with subjective cognitive impairment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This pilot RCT aims to evaluate the feasibility of a theory-based, tailored Mediterranean lifestyle education intervention (THINK-MED) to encourage behaviour change among participants who have subjective cognitive impairment.
This study will be a 6 month randomised controlled trial (RCT) with a total of 30 participants who will be randomised to 1 of 3 groups:
- Group 1 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource on one occasion at baseline (n=10)
- Group 2 will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource at monthly intervals for 5 months, with an initial face-to-face visit from the research dietitian (month 1) and accompanied by telephone feedback (month 2-5) (n=10)
- Group 3 is a control group. Participants in this group will receive the "THINK-MED" Mediterranean Lifestyle Education for Memory resource after completing the 6 month study (n=10)
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Belfast, United Kingdom
- Queen's University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Have subjective cognitive impairment - Montreal Cognitive Assessment (MoCA) score ≥ 26/30
- Mediterranean diet score (MDS) ≤ 4 (Estruch et al. 2006)
- Willing to make changes to their diet
Exclusion Criteria:
- Diagnosis of dementia
- MoCA score of ≤ 25/30
- Individuals with a visual or English language impairment
- Psychiatric problems e.g. depression
- Significant medical comorbidity
- Body Mass Index (BMI) ≤ 19 and ≥ 40 kg/m2
- Excessive alcohol consumption
- Dietary restrictions/allergies that would substantially limit ability to complete study requirements
- Inability to provide informed consent
- History of, or comorbid condition which may alter performance on cognitive tests e.g. stroke, head injury, Parkinson's disease, learning disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Group 1: "THINK-MED" resource (baseline)
The "THINK-MED" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards.
Participants will receive this resource on one occasion at baseline (n=10)
|
The "THINK-MED" resource contains an information booklet, recipe books, menu plan cards, shopping list cards and goal setting cards.
Participants will receive this resource on one occasion at baseline.
|
|
Experimental: Group 2: "THINK-MED" resource (staged)
This group of participants will receive the "THINK-MED" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian (n=10)
|
This group of participants will receive the "THINK-MED" resource at monthly intervals for 5 months accompanied by telephone feedback from the research dietitian
|
|
Placebo Comparator: Group 3: Control
Participants will receive the "THINK-MED" resource after their final 6 month study visit (i.e.
delayed intervention) (n=10)
|
Participants will receive the "THINK-MED" resource after their final 6 month study visit (i.e.
delayed intervention).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mediterranean Diet Score (MDS) at 6 months
Time Frame: Baseline, 6 months
|
Mediterranean dietary intake will be measured by a validated questionnaire with a increase in score by greater than or equal to 3 points at 6 months indicating adoption (maximum score 14)
|
Baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometric measurements
Time Frame: Baseline, 6 months
|
Weight and height measurements to calculate BMI
|
Baseline, 6 months
|
|
Muscle Strength
Time Frame: Baseline, 6 months
|
Measured using a grip-strength dynamometer
|
Baseline, 6 months
|
|
Cognitive Assessment
Time Frame: Baseline, 6 months
|
A comprehensive cognitive assessment will be performed, including: global cognition, motor skills, executive function episodic/visual memory, and information processing and sustained attention using a validated neuropsychological test battery (Cantab Cognitive Battery, Cambridge Cognition Ltd.)
|
Baseline, 6 months
|
|
Barriers to consuming a Mediterranean Diet questionnaire
Time Frame: Baseline, 6 months
|
Dietary behaviour change questionnaire to measure adherence to a Mediterranean diet
|
Baseline, 6 months
|
|
Blood Sample
Time Frame: Baseline, 6 months
|
A blood sample will be taken from participants to be stored for analysis of biomarkers of MD adherence and biomarkers of neurodegenerative disease risk.
|
Baseline, 6 months
|
|
Change in Lifestyle questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure change in lifestyle behaviours
|
Baseline, 6 months
|
|
Dietary Quality of Life questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure dietary quality of life
|
Baseline, 6 months
|
|
Mediterranean Diet Knowledge questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants Mediterranean diet knowledge
|
Baseline, 6 months
|
|
Staging Algorithm Questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants readiness to change their diet and lifestyle
|
Baseline, 6 months
|
|
Mediterranean Diet self-efficacy questionnaire
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants self-efficacy
|
Baseline, 6 months
|
|
Change in Physical Activity at 6 months
Time Frame: Baseline, 6 months
|
Physical activity will be measured by the Recent Physical Activity Questionnaire (RPAQ)
|
Baseline, 6 months
|
|
Geriatric Depression Scale
Time Frame: Baseline, 6 months
|
Depressive symptoms will be measured by the Geriatric Depression Scale Questionnaire, with a score greater than 5 indicating depressive symptoms
|
Baseline, 6 months
|
|
Functional Assessment (1)
Time Frame: Baseline, 6 months
|
Measured by the instrumental activities of daily living questionnaire (IADL) by Lawton and Brody Measured by the instrumental activities of daily living scale (IADL) by Lawton and Brody (1969) questionnaire
|
Baseline, 6 months
|
|
Functional Assessment (2)
Time Frame: Baseline, 6 months
|
Measured by the Bristol activities of daily living (Bucks et al. 1996) questionnaire
|
Baseline, 6 months
|
|
4 day food diary
Time Frame: Baseline, 6 months
|
A food diary will be completed to assess compliance with a Mediterranean diet
|
Baseline, 6 months
|
|
Rand Short Form-36 HEALTH SURVEY
Time Frame: Baseline, 6 months
|
A questionnaire to measure participants views and beliefs on health
|
Baseline, 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Process Evaluation (1) - telephone contact evaluation
Time Frame: Up to 3 months post intervention
|
Determination individual participation and engagement with the intervention by reviewing telephone contact log record and telephone checklist evaluation
|
Up to 3 months post intervention
|
|
Process Evaluation (2) - study records
Time Frame: Up to 3 months post intervention
|
A review of study records- including attrition rates, reason for dropout
|
Up to 3 months post intervention
|
|
Process Evaluation (3) - structured interviews
Time Frame: Up to 3 months post intervention
|
Post intervention structured interviews for participant evaluation of the intervention programme and dietary educational materials
|
Up to 3 months post intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jayne Woodside, PhD, Queen's University, Belfast
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18/NI/0077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Subjective Cognitive Impairment
-
BaycrestNot yet recruitingSubjective Cognitive Impairment | Subjective Cognitive Decline (SCD)Canada
-
IRCCS Policlinico S. DonatoAzienda Ospedaliero-Universitaria CareggiRecruitingSubjective Cognitive Impairment | Subjective Memory Decline | Subjective Cognitive Decline (SCD) | Subjective Memory Complaint | Subjective Cognitive Concerns | Subjective Cognitive Complaints (SCCs)Italy
-
Eli Lilly and CompanyRecruitingSubjective Cognitive ImpairmentUnited States
-
Hebrew University of JerusalemMinistry of Health, IsraelRecruitingSubjective Cognitive Impairment | Subjective Cognitive Decline (SCD) | Subjective Memory ComplaintsIsrael
-
Stanford UniversityRecruitingMild Cognitive Impairment | Subjective Cognitive ImpairmentUnited States
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
University of California, San FranciscoNational Institute on Aging (NIA)CompletedCognitive Impairment | Mild Cognitive Impairment (MCI) | Subjective Cognitive DeclineUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Baycrest; Alzheimer Society of... and other collaboratorsRecruitingCognitive Change | Mild Cognitive Impairment | Lifestyle Intervention | Dementia Prevention | Subjective Cognitive Impairment | Dementia EducationCanada
-
Chang Gung Memorial HospitalRecruitingMild Cognitive Impairment | Subjective Cognitive Decline | Cognitive Function AssessmentTaiwan
-
The University of Texas Health Science Center,...DPRIT Seed GrantNot yet recruitingMild Cognitive Impairment | Subjective Cognitive Decline (SCD)United States
Clinical Trials on "THINK-MED" resource (baseline)
-
Queen's University, BelfastWellcome TrustCompletedMild Cognitive ImpairmentUnited Kingdom